Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19

Background: Endotheliopathy is a common pathologic finding in patients with acute and long COVID-19. It may be associated with disease severity and predispose patients to long-term complications. Plasma levels of a proteoglycan, syndecan-1, are found to be significantly elevated in patients with COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Quan, Ye, Zhan, Bignotti, Antonia, Zheng, X. Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865511/
https://www.ncbi.nlm.nih.gov/pubmed/36675479
http://dx.doi.org/10.3390/jcm12020552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865511/
https://www.ncbi.nlm.nih.gov/pubmed/36675479
http://dx.doi.org/10.3390/jcm12020552

Ejemplares similares